Clinical Trial Update: A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity ) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a Phase 2/3 trial comparing MG01CI 1400 mg to placebo in adults with ADHD, predomin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• MG01CI

Snippet

Sponsor: Alcobra Ltd. | Conditions: ADHD, Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-03-28